<?xml version="1.0" encoding="UTF-8"?>
<ref id="B80-viruses-12-00339">
 <label>80.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Andtbacka</surname>
    <given-names>R.H.</given-names>
   </name>
   <name>
    <surname>Kaufman</surname>
    <given-names>H.L.</given-names>
   </name>
   <name>
    <surname>Collichio</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Amatruda</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Senzer</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Chesney</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Delman</surname>
    <given-names>K.A.</given-names>
   </name>
   <name>
    <surname>Spitler</surname>
    <given-names>L.E.</given-names>
   </name>
   <name>
    <surname>Puzanov</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Agarwala</surname>
    <given-names>S.S.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma</article-title>
  <source>J. Clin. Oncol.</source>
  <year>2015</year>
  <volume>33</volume>
  <fpage>2780</fpage>
  <lpage>2788</lpage>
  <pub-id pub-id-type="doi">10.1200/JCO.2014.58.3377</pub-id>
  <pub-id pub-id-type="pmid">26014293</pub-id>
 </element-citation>
</ref>
